ArticlebioRxiv : the preprint server for biology2025
Profiling miRNAs involved in Human Oligodendrocyte Precursor Cell Differentiation and Maturation.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
9 authors.
Funding
Abstract
MicroRNAs (miRNAs) are evolutionarily conserved post-transcriptional regulators that play critical roles in cellular development and differentiation across species. Although the importance of miRNAs in oligodendrocyte lineage cell (OLLC) differentiation has been extensively studied in rodent models, their roles in human OL development remain less understood. To address this gap, we used a human embryonic stem cell (hESC) reporter system designed to study human OLs and OL progenitor cells (OPCs). Using an optimized differentiation protocol, we used the reporter hESCs to generate and isolate well-characterized OLLCs at specific developmental stages and performed next-generation sequencing-based miRNA profiling to identify stage-specific miRNAs enriched during OL lineage specification and maturation. In addition to canonical miRNAs known to be enriched at various stages of OL development, our study identified several lesser-known miRNAs with distinct stage-specific enrichment patterns that may serve as useful molecular markers for classifying human CNS cell types in future studies. Target analysis of OPC- and OL-enriched miRNAs revealed key genes, including transcription factors ZNF488 and DLX1, cytoskeletal regulator CSNK2B, and potassium channel gene KCNJ1, along with key signaling pathways such as AKT, SMAD2/3, estrogen receptor, and insulin signaling, which regulate OPC and OL lineage function. These findings advance our understanding of the OLLC-specific miRNAs, and miRNA-mediated regulatory networks governing human OL differentiation and maturation and provide promising therapeutic targets for future studies aimed at restoring myelin integrity and improving outcomes in demyelinating diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.